Episode
What Patients Want in Non-Melanoma Skin Cancer Treatment
- Published
- Mar 31, 2026
- Duration seconds
- 510
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-distinctive-dermatologist-6371768/episodes/what-patients-want-in-non-melanoma-skin-cancer-treatment/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-distinctive-dermatologist-6371768/what-patients-want-in-non-melanoma-skin-cancer-treatment.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
For the past three-plus years, The Distinctive Dermatologist has presented many tactics and strategies for making your practice stand out from your competition. We've focused, as well, on the importance of the patient experience. Our sponsor, GentleCure from SkinCure Oncology has consistently been a leader in advocating for patient choice. Abundant research demonstrates that when patients are presented with clinically established options, they feel more in control, and their satisfaction with -- and advocacy for -- your clinic is enhanced. On this episode, Kerwin Brandt, CEO and co-founder of SkinCure Oncology, talks about the amazing growth of the non-surgical option presented by IG-SRT and how patients are learning about and asking for the GentleCure approach to treat their non-melanoma skin cancer lesions.